Compound ID | 552
Class: Fluoroquinolone
| Agent Type: | Synthetic; Small molecule; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Mycobacterium tuberculosis, Mycobacterium fortuitum, and Mycobacterium smegmatis |
| Description: | Renau TE, Gage JW, Dever JA, et al. Antituberculosis activity and side effect profiles of 8 new quinolones optimised for antimycobacterial effects. 36th-Intersci-Conf-Antimicrobial-Agents-Chemother 1996; 136. |
| Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
| Year first mentioned: | 1996 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/459966 |
| Citation: | https://journals.asm.org/doi/10.1128/aac.40.10.2363 |